Delivery Order SPE2DB22D1200-SPE2DB25FN3HM
- Not listed
- The Defense Logistics Agency awarded a $7,980.37 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be supplied from the vendor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant...
- The Defense Logistics Agency awarded a delivery order valued at $3,011.76 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used primarily for stroke prevention and blood clot...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,896.80 for 60 tablets of Eliquis 5 mg on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used to reduce stroke risk and treat blood clots, reflecting the Defense Logistics Agency...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,257.64 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a brand-name anticoagulant...
- On July 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units). The contract, executed on a firm fixed-price basis with no set-aside designation, is scheduled for completion by July 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order through its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $10,764.56. This firm fixed-price delivery order, which is expected to be completed by July 21, 2025, represents a competitively awarded procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a...
- The Defense Logistics Agency awarded a delivery order valued at $49,762.80 to AmerisourceBergen Drug Corp for ELIQUIS 5 mg tablets (60-count units) on July 18, 2025, with completion expected by July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ELIQUIS is a widely-used anticoagulant medication for stroke prevention and thromboembolism...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $17,176.10 delivery order from the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count). This firm fixed-price, competitively awarded contract represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $14,873.42 under a firm fixed-price contract. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements, with performance to be completed by July 21, 2025, and fulfillment from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $18,987.24 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on July 22, 2025, with a completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used to reduce the risk of stroke and blood clots, and this order supports pharmaceutical...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB25FN3HMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $45,565.02 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order, which is not set-aside, is set to be completed by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used in military and federal healthcare systems to prevent blood clots and reduce stroke risk in patients with atrial fibrillation and other conditions. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle that runs through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen routinely fulfills competitively awarded delivery orders for brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.6k | 7/22/25 |